Vice Provost and Dean of Research


Showing 1-100 of 1,154 Results

  • Geoffrey Abrams, MD

    Geoffrey Abrams, MD

    Associate Professor of Orthopaedic Surgery

    Current Research and Scholarly InterestsDr. Abrams' research is focused on elucidating the pathobiology behind tendinoapthy and developing new treatment modalities for the disease. Specifically, his team is studying the role of micro-RNA as it relates to chronic inflammation and stem cell differentiation in the development and perpetuation of chronic tendinopathy.

  • Monther Abu-Remaileh

    Monther Abu-Remaileh

    Assistant Professor of Chemical Engineering and of Genetics

    Current Research and Scholarly InterestsWe study the role of the lysosome in metabolic adaptation using subcellular omics approaches, functional genomics and innovative biochemical tools. We apply this knowledge to understand how lysosomal dysfunction leads to human diseases including neurodegeneration, cancer and metabolic syndrome.

  • Ehsan Adeli

    Ehsan Adeli

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Public Mental Health and Populations Sciences) and, by courtesy, of Computer Science and of Biomedical Data Science

    Current Research and Scholarly InterestsMy research lies in the intersection of Machine Learning, Computer Vision, Healthcare, Ambient Intelligence, and Computational Neuroscience.

  • Nima Aghaeepour

    Nima Aghaeepour

    Anesthesiology, Perioperative and Pain Medicine Professor and Professor of Pediatrics (Neonatology) and of Biomedical Data Science

    BioNima Aghaeepour is a machine learning and artificial intelligence scientist and the Anesthesiology, Perioperative and Pain Medicine II Endowed Professor, and Professor of Pediatrics, and of Biomedical Data Science at Stanford University. His laboratory develops computational methods to study clinical and biological modalities in translational settings.

    Dr. Aghaeepour primarily focuses on leveraging multiomics studies, wearable devices, and electronic health records to address clinical challenges in perioperative care and maternal and child health, with a particular focus on interventional settings including operating rooms, ICUs, labor and delivery, and NICUs. Prior to his faculty role, Dr. Aghaeepour earned his B.Sc. in Computer Science from the University of Tehran, followed by a Ph.D. in Bioinformatics from the University of British Columbia and a postdoctoral fellowship at Stanford University.

    Dr. Aghaeepour is an alumnus of Stanford's Graduate School of Business Ignite program, a Biodesign Faculty Fellow, and a SPARK fellow and his laboratory provides training on the interface of academia and entrepreneurship. He regularly co-founds or serves on scientific advisory boards of startup companies and is committed to fostering entrepreneurship among his trainees through Stanford's unique programs. Beyond his scientific pursuits, Dr. Aghaeepour is an experienced pilot, skydiver, and wingsuiter.

  • Biafra Ahanonu

    Biafra Ahanonu

    Assistant Professor of Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsStudy the neural and molecular mechanisms of pain processing.

  • Aijaz Ahmed, MD

    Aijaz Ahmed, MD

    Professor of Medicine (Gastroenterology and Hepatology)

    BioDr. Ahmed is an internationally recognized hepatologist with expertise in the treatment of acute and chronic liver diseases. He is a board-certified specialist in gastroenterology and hepatology, transplant hepatology, and obesity medicine. Currently, he serves as the Medical Director of the Adult Liver Transplant Program at Stanford University.

    Dr. Ahmed graduated from Dow Medical College, Karachi, Pakistan. He completed his residency training in Internal Medicine at Brown University, Providence, RI and fellowship training in Gastroenterology and Hepatology at Stanford University. During his fellowship, he focused on clinical and research training in General and Transplant Hepatology.

    For patients under his care, Dr. Ahmed remains dedicated to creating a personalized, comprehensive, and above-all a compassionate treatment plan. He outlines the diagnostic and follow-up management pathway in an individualized fashion; he updates his patients and their family/support at each step of the decision-making process; and he focuses on prioritizing the wishes of his patients and their family/support for an optimal outcome and quality of life.

    Dr. Ahmed remains clinically active and has been instrumental in establishing a wide network of hepatology outreach clinics in remote and underserved regions of California and Nevada.

    In addition to his patient care responsibilities, Dr. Ahmed remains committed to the educational mission of Stanford ford University. He remains deeply interested in mentoring trainees and students al levels from undergraduates to trainee physicians and junior colleagues. Dr. Ahmed has received several teaching awards during his career.

    Dr. Ahmed’s research interests include 1) multidisciplinary approach to nonalcoholic fatty liver disease (NAFLD), 2) disparities in the management of chronic liver disease, 3) improving screening and management of hepatocellular carcinoma (HCC), and 4) outcomes research in NAFLD, HCC, viral hepatitis, alcoholic liver disease, and liver transplantation. He heads a busy and productive outcomes research team. In addition, he collaborates with basic scientists and is participating in several translational research projects at Stanford University.

    He has published his findings in textbooks, abstracts, case reports, and high- profile medical journals including Gastroenterology, Journal of Hepatology, Hepatology American Journal of Gastroenterology, and other well-renowned peer-reviewed publications.

    Dr. Ahmed and his team has made presentations to his peers at many national and international conferences: the American Association for the Study of Liver Disease, International Liver Congress, European Association for the Study of the Liver, Asian Pacific Association for the Study of the Liver, and more. His presentations have addressed leading-edge approaches to the treatment of chronic liver disease, liver cancer, and liver failure. He also has presented his insights into the gastrointestinal impact of COVID-19.

    For his clinical, research, and teaching achievements, Dr. Ahmed has earned extensive recognition. His honors include being named as one of America’s Top Physicians by the Consumers’ Research Council of America.

    He is an active member of the American Gastroenterological Association and the American Association for the Study of Liver Diseases.

  • Alex Aiken

    Alex Aiken

    Alcatel-Lucent Professor of Communications and Networking, Professor of Particle Physics and Astrophysics, and of Photon Science

    BioAlex Aiken is the Alcatel-Lucent Professor of Computer Science at Stanford. Alex received his Bachelors degree in Computer Science and Music from Bowling Green State University in 1983 and his Ph.D. from Cornell University in 1988. Alex was a Research Staff Member at the IBM Almaden Research Center (1988-1993) and a Professor in the EECS department at UC Berkeley (1993-2003) before joining the Stanford faculty in 2003. His research interest is in areas related to programming languages.

  • Raag Airan

    Raag Airan

    Associate Professor of Radiology (Neuroimaging and Neurointervention) and, by courtesy, of Materials Science & Engineering and of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsOur goal is to develop and clinically implement new technologies for high-precision and noninvasive intervention upon the nervous system. Every few millimeters of the brain is functionally distinct, and different parts of the brain may have counteracting responses to therapy. To better match our therapies to neuroscience, we develop techniques that allow intervention upon only the right part of the nervous system at the right time, using technologies like focused ultrasound and nanotechnology.

  • Fernando Alarid-Escudero

    Fernando Alarid-Escudero

    Assistant Professor of Health Policy

    BioFernando Alarid-Escudero, Ph.D., is an Assistant Professor of Health Policy at Stanford University School of Medicine. He is a decision scientist specializing in disease simulation, decision-analytic modeling, and cost-effectiveness analysis to inform health policy questions that cannot be readily answered through clinical studies alone. He has also developed novel methods to quantify the value of future research and calibrate simulation models using emulator-based Bayesian methods. Dr. Alarid-Escudero is a member of three cancers (colorectal [CRC], bladder, and gastric) of the Cancer Intervention and Surveillance Modeling Network (CISNET) consortium, a group of investigators sponsored by the National Cancer Institute in the U.S. that uses simulation modeling to evaluate the impact of cancer control interventions (e.g., prevention, screening, and treatment) on population trends in incidence and mortality. Dr. Alarid-Escudero co-founded the Decision Analysis in R for Technologies in Health (DARTH) workgroup (http://darthworkgroup.com) and the Collaborative Network on Value of Information (ConVOI; https://www.convoi-group.org), international and multi-institutional collaborative efforts that develop transparent and open-source solutions to implement decision analysis and quantify the value of potential future investigation for health policy analysis.

  • Ash A. Alizadeh, MD/PhD

    Ash A. Alizadeh, MD/PhD

    Moghadam Family Professor

    Current Research and Scholarly InterestsMy research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.

    Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.

  • Nicolas Altemose

    Nicolas Altemose

    Assistant Professor of Genetics

    Current Research and Scholarly InterestsThe Altemose Lab develops new experimental and analytical tools to study how chromatin proteins organize and regulate complex regions of the human genome.

  • Russ B. Altman

    Russ B. Altman

    Kenneth Fong Professor and Professor of Bioengineering, of Genetics, of Medicine, of Biomedical Data Science, Senior Fellow at the Stanford Institute for Human-Centered AI and Professor, by courtesy, of Computer Science

    Current Research and Scholarly InterestsI refer you to my web page for detailed list of interests, projects and publications. In addition to pressing the link here, you can search "Russ Altman" on http://www.google.com/

  • Derek F. Amanatullah, M.D., Ph.D.

    Derek F. Amanatullah, M.D., Ph.D.

    Associate Professor of Orthopaedic Surgery

    BioDerek F. Amanatullah, M.D., Ph.D., is an internationally recognized expert in hip and knee replacement. He helps patients with advanced arthritis and complex joint problems regain mobility and confidence. In addition to primary hip and knee replacements, he is frequently sought out for difficult revision surgeries, often fixing complications such as infection, instability, or persistent pain from prior procedures.

    Dr. Amanatullah focuses on what truly lowers surgical risk: the skill, preparation, and coordination of the surgical team. He believes patients deserve care that relies on evidence and expert technique rather than placing the burden solely on weight or other patient factors. This patient-centered approach was highlighted by The New York Times.

    As a researcher, he discovered an important new way certain infections can remain “hidden” in the body, shaping how surgeons diagnose and treat joint infections. His impact on the field earned him induction into The Knee Society, an honor held by fewer than 200 surgeons worldwide. Patients choose Dr. Amanatullah for his precision, innovation, and commitment to providing the safest, most effective joint care possible.

  • Kanwaljeet S. Anand

    Kanwaljeet S. Anand

    Professor of Pediatrics (Pediatric Critical Care) and of Anesthesiology, Perioperative and Pain Medicine
    On Partial Leave from 11/01/2025 To 03/31/2026

    Current Research and Scholarly InterestsDr. Anand is a translational clinical researcher who pioneered research on the endocrine-metabolic stress responses of infants undergoing surgery and developed the first-ever scientific rationale for pain perception in early life. This provided a framework for newer methods of pain assessment, numerous clinical trials of analgesia/anesthesia in newborns, infants and older children. His research focus over the past 30+ years has contributed fundamental knowledge about pediatric pain/stress, long-term effects of pain in early life, management of pain, mechanisms for opioid tolerance and withdrawal. Current projects in his laboratory are focused on developing biomarkers for repetitive pain/stress in critically ill children and the mechanisms underlying sedative/anesthetic neurotoxicity in the immature brain. He designed and directed many randomized clinical trials (RCT), including the largest-ever pediatric analgesia trial studying morphine therapy in ventilated preterm neonates. He has extensive experience in clinical and translational research from participating in collaborative networks funded by NIMH, NINDS, or NICHD, a track-record of excellent collaboration across multiple disciplines, while achieving success with large research teams like the Collaborative Pediatric Critical Care Research Network (CPCCRN). He played a leadership roles in CANDLE (Condition Affecting Neuro-Development & Learning in Early infancy) and other activities of the Urban Child Institute and UT Neuroscience Institute. More recently, he led the NeoOpioid Consortium funded by the European Commission, which collected data from 243 NICUs in 18 European countries.

  • Katrin Andreasson

    Katrin Andreasson

    Edward F. and Irene Thiele Pimley Professor of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsOur research focuses on understanding how immune responses initiate and accelerate synaptic and neuronal injury in age-related neurodegeneration, including models of Alzheimer's disease and Parkinson's disease. We also focus on the role of immune responses in aggravating brain injury in models of stroke. Our goal is the identification of critical immune pathways that function in neurologic disorders and that can be targeted to elicit disease modifying effects.

  • Jason Andrews

    Jason Andrews

    Professor of Medicine (Infectious Diseases) and, by courtesy, of Epidemology

    Current Research and Scholarly InterestsOur laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings. We draw upon multiple fields including mathematical modeling, microbial genetics, field epidemiology, statistical inference and biodesign to work on challenging problems in infectious diseases, with an emphasis on tuberculosis and tropical diseases.

  • Thomas P. Andriacchi

    Thomas P. Andriacchi

    Professor of Mechanical Engineering and of Orthopaedic Surgery, Emeritus

    Current Research and Scholarly InterestsProfessor Andriacchi's research focuses on the biomechanics of human locomotion and applications to medical devices, sports injury, osteoarthritis, the anterior cruciate ligament and low cost prosthetic limbs

  • Lay Teng Ang

    Lay Teng Ang

    Assistant Professor of Urology

    BioAs a stem cell biologist, I aim to understand the mechanisms through which stem cells differentiate into progressively specialized cell types and to harness this knowledge to artificially generate pure populations of desired cell types from stem cells. My work over the past ten years has centered on pluripotent stem cells (PSCs, which include embryonic and pluripotent stem cells), which can generate any of the hundreds of diverse cell types in the body. However, it has been notoriously challenging to guide PSCs to differentiate into a pure population of a given cell type. Current differentiation strategies typically generate heterogeneous cell populations unsuitable for basic research or clinical applications. To address this challenge, I mapped the cascade of branching lineage choices through which PSCs differentiate into various endodermal and mesodermal cell types. I then developed effective methods to differentiate PSCs into specific lineages by providing the extracellular signal(s) that specify a given lineage while inhibiting the signals that induce the alternate fate(s), enabling the generation of highly-pure human heart and bone (Loh & Chen et al., 2016; Cell) and liver (Loh & Ang et al., 2014; Cell Stem Cell) from PSCs. My laboratory currently focuses on differentiating human PSCs into liver progenitors (Ang et al., 2018; Cell Reports) and blood vessel cells (Ang et al., 2022; Cell).

    I earned my Ph.D. jointly from the University of Cambridge and A*STAR and was subsequently appointed as a Research Fellow and, later, a Senior Research Fellow at the Genome Institute of Singapore. I then moved my laboratory to Stanford University as a Siebel Investigator and Instructor at the Stanford Institute for Stem Cell Biology & Regenerative Medicine. In 2024, I am jointly appointed in the Stanford Department of Urology and Stem Cell Institute as an Assistant Professor. My laboratory has been supported by the Stanford Maternal & Child Health Research Institute, California Institute for Regenerative Medicine, Siebel Investigatorship, Additional Ventures, and other sources.

  • Michael Angelo

    Michael Angelo

    Associate Professor of Pathology

    BioMichael Angelo, MD PhD is a board-certified pathologist and assistant professor in the department of Pathology at Stanford University School of Medicine. Dr. Angelo is a leader in high dimensional imaging with expertise in tissue homeostasis, tumor immunology, and infectious disease. His lab has pioneered the construction and development of Multiplexed Ion Beam Imaging by time of flight (MIBI-TOF). MIBI-TOF uses secondary ion mass spectrometry and metal-tagged antibodies to achieve rapid, simultaneous imaging of dozens of proteins at subcellular resolution. In recognition of this achievement, Dr. Angelo received the NIH Director’s Early Independence award in 2014. His lab has since used this novel technology to discover previously unknown rule sets governing the spatial organization and cellular composition of immune, stromal, and tumor cells within the tumor microenvironment in triple negative breast cancer. These findings were found to be predictive of single cell expression of several immunotherapy drug targets and of 10-year overall survival. This effort has led to ongoing work aimed at elucidating structural mechanisms in the TME that promote recruitment of cancer associated fibroblasts, tumor associated macrophages, and extracellular matrix remodeling. Dr. Angelo is the recipient of the 2020 DOD Era of Hope Award and a principal investigator on multiple extramural awards from the National Cancer Institute, Breast Cancer Research Foundation, Parker Institute for Cancer Immunotherapy, the Bill and Melinda Gates Foundation, and the Human Biomolecular Atlas (HuBMAP) initiative.

  • Martin S. Angst

    Martin S. Angst

    Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)

    Current Research and Scholarly InterestsOur laboratory studies biological and clinical determinants of human resilience using surgery as an injury model.

  • Justin P. Annes M.D., Ph.D.

    Justin P. Annes M.D., Ph.D.

    Associate Professor of Medicine (Endocrinology)

    Current Research and Scholarly InterestsThe ANNES LABORATORY of Molecular Endocrinology: Leveraging Chemical Biology to Treat Endocrine Disorders

    DIABETES
    The prevalence of diabetes is increasing at a staggering rate. By the year 2050 an astounding 25% of Americans will be diabetic. The goal of my research is to uncover therapeutic strategies to stymie the ensuing diabetes epidemic. To achieve this goal we have developed a variety of innovate experimental approaches to uncover novel approaches to curing diabetes.

    (1) Beta-Cell Regeneration: Diabetes results from either an absolute or relative deficiency in insulin production. Our therapeutic strategy is to stimulate the regeneration of insulin-producing beta-cells to enhance an individual’s insulin secretion capacity. We have developed a unique high-throughput chemical screening platform which we use to identify small molecules that promote beta-cell growth. This work has led to the identification of key molecular pathways (therapeutic targets) and candidate drugs that promote the growth and regeneration of islet beta-cells. Our goal is to utilize these discoveries to treat and prevent diabetes.

    (2) The Metabolic Syndrome: A major cause of the diabetes epidemic is the rise in obesity which leads to a cluster of diabetes- and cardiovascular disease-related metabolic abnormalities that shorten life expectancy. These physiologic aberrations are collectively termed the Metabolic Syndrome (MS). My laboratory has developed an original in vivo screening platform t to identify novel hormones that influence the behaviors (excess caloric consumption, deficient exercise and disrupted sleep-wake cycles) and the metabolic abnormalities caused by obesity. We aim to manipulate these hormone levels to prevent the development and detrimental consequences of the MS.

    HEREDIATY PARAGAGLIOMA SYNDROME
    The Hereditary Paraganglioma Syndrome (hPGL) is a rare genetic cancer syndrome that is most commonly caused by a defect in mitochondrial metabolism. Our goal is to understand how altered cellular metabolism leads to the development of cancer. Although hPGL is uncommon, it serves as an excellent model for the abnormal metabolic behavior displayed by nearly all cancers. Our goal is to develop novel therapeutic strategies that target the abnormal behavior of cancer cells. In the laboratory we have developed hPGL mouse models and use high throughput chemical screening to identify the therapeutic susceptibilities that result from the abnormal metabolic behavior of cancer cells.

    As a physician scientist trained in clinical genetics I have developed expertise in hereditary endocrine disorders and devoted my efforts to treating families affected by the hPGL syndrome. By leveraging our laboratory expertise in the hPGL syndrome, our care for individuals who have inherited the hPGL syndrome is at the forefront of medicine. Our goal is to translate our laboratory discoveries to the treatment of affected families.

  • Eric Appel

    Eric Appel

    Associate Professor of Materials Science and Engineering, Senior Fellow at the Woods Institute for the Environment and Associate Professor, by courtesy, of Pediatrics (Endocrinology) and of Bioengineering

    Current Research and Scholarly InterestsThe underlying theme of the Appel Lab at Stanford University integrates concepts and approaches from supramolecular chemistry, natural/synthetic materials, and biology. We aim to develop supramolecular biomaterials that exploit a diverse design toolbox and take advantage of the beautiful synergism between physical properties, aesthetics, and low energy consumption typical of natural systems. Our vision is to use these materials to solve fundamental biological questions and to engineer advanced healthcare solutions.

  • Amin Arbabian

    Amin Arbabian

    Professor of Electrical Engineering

    Current Research and Scholarly InterestsMy group's research covers RF circuits and system design for (1) biomedical, (2) sensing, and (3) Internet of Things (IoT) applications.

  • Ronald L. Ariagno

    Ronald L. Ariagno

    Professor (Clinical) of Pediatrics, Emeritus

    Current Research and Scholarly InterestsDevelopmental Physiology and Sudden Infant Death Syndrome Research Laboratory closed in 2008.

    Current effort, as Chair of Task Force and neonatal consult at the FDA, is to establish through consensus a culture of investigation and collaboration for all clinical neonatology practices: academic, corporate and community based to maximize the opportunity to participate in research effort needed for the regulatory approval of neonatal therapeutics to improve the outcome of critically ill infants.

  • Kevin Arrigo

    Kevin Arrigo

    Donald and Donald M. Steel Professor of Earth Sciences and Senior Fellow at the Woods Institute for the Environment

    Current Research and Scholarly InterestsInvestigates role of ocean biology in gobal carbon and nutrient cycles.

  • Steven Artandi, MD, PhD

    Steven Artandi, MD, PhD

    Laurie Kraus Lacob Director of the Stanford Cancer Institute (SCI), Jerome and Daisy Low Gilbert Professor and Professor of Biochemistry

    Current Research and Scholarly InterestsTelomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function, aging and human disease. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.

  • Ann M. Arvin

    Ann M. Arvin

    Lucile Salter Packard Professor of Pediatrics and Professor of Microbiology and Immunology, Emerita

    Current Research and Scholarly InterestsOur laboratory investigates the pathogenesis of varicella zoster virus (VZV) infection, focusing on the functional roles of particular viral gene products in pathogenesis and virus-cell interactions in differentiated human cells in humans and in Scid-hu mouse models of VZV cell tropisms in vivo, and the immunobiology of VZV infections.

  • Euan A. Ashley

    Euan A. Ashley

    Roger and Joelle Burnell Professor of Genomics and Precision Health, Arthur L. Bloomfield Professor of Medicine and Professor of Genetics, of Biomedical Data Science and, by courtesy, of Pathology

    Current Research and Scholarly InterestsThe Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.

  • Laura Attardi

    Laura Attardi

    Catharine and Howard Avery Professor of the School of Medicine and Professor of Genetics

    Current Research and Scholarly InterestsOur research is aimed at defining the pathways of p53-mediated apoptosis and tumor suppression, using a combination of biochemical, cell biological, and mouse genetic approaches. Our strategy is to start by generating hypotheses about p53 mechanisms of action using primary mouse embryo fibroblasts (MEFs), and then to test them using gene targeting technology in the mouse.

  • Jeffrey Axelrod

    Jeffrey Axelrod

    Professor of Pathology

    Current Research and Scholarly InterestsGenetic and cell biological analyses of signals controlling cell polarity and morphogenesis. Frizzled signaling and cytoskeletal organization.

  • Rosa Bacchetta

    Rosa Bacchetta

    Professor (Research) of Pediatrics (Stem Cell Transplantation)

    Current Research and Scholarly InterestsIn the coming years, I plan to further determine the genetic and immunological basis of diseases with autoimmunity or immune dysregulation in children. I believe that much can still be learned from the in depth mechanistic studies of pediatric autoimmune diseases. Genomic analysis of the patients' samples has become possible which may provide a rapid indication of altered target molecules. I plan to implement robust functional studies to define the consequences of these genetic abnormalities and bridge them to the patient's clinical phenotype.

    Understanding functional consequences of gene mutations in single case/family first and then validating the molecular and cellular defects in other patients with similar phenotypes, will anticipate and complement cellular and gene therapy strategies.

    For further information please visit the Bacchetta Lab website:
    http://med.stanford.edu/bacchettalab.html

  • Stephen A. Baccus

    Stephen A. Baccus

    Professor of Neurobiology

    Current Research and Scholarly InterestsWe study how the neural circuitry of the vertebrate retina encodes visual information and performs computations. To control and measure the retinal circuit, we present visual images while performing simultaneous two-photon imaging and multielectrode recording. We perturb the circuit as it operates using simultaneous intracellular current injection and multielectrode recording, and use the resulting large data sets to construct models of retinal computation.

  • Jeremy Bailenson

    Jeremy Bailenson

    Thomas More Storke Professor, Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Education

    BioJeremy Bailenson is founding director of Stanford University’s Virtual Human Interaction Lab, Thomas More Storke Professor in the Department of Communication, Professor (by courtesy) of Education, Professor (by courtesy) Program in Symbolic Systems, and a Senior Fellow at the Woods Institute for the Environment. He has served as Director of Graduate Studies in the Department of Communication for fifteen years. He earned a B.A. from the University of Michigan in 1994 and a Ph.D. in cognitive psychology from Northwestern University in 1999. He spent four years at the University of California, Santa Barbara as a Post-Doctoral Fellow and then an Assistant Research Professor.

    Bailenson studies the psychology of Virtual and Augmented Reality, in particular how virtual experiences lead to changes in perceptions of self and others. His lab builds and studies systems that allow people to meet in virtual space, and explores the changes in the nature of social interaction. His most recent research focuses on how virtual experiences can transform education, environmental conservation, empathy, and health. He is the recipient of the Dean’s Award for Distinguished Teaching at Stanford. In 2020, IEEE recognized his work with “The Virtual/Augmented Reality Technical Achievement Award”.

    He has published more than 250 academic papers, spanning the fields of communication, computer science, education, environmental science, law, linguistics, marketing, medicine, political science, and psychology. His work has been continuously funded by the National Science Foundation for over 25 years.

    His first book Infinite Reality, co-authored with Jim Blascovich, emerged as an Amazon Best-seller eight years after its initial publication, and was quoted by the U.S. Supreme Court. His new book, Experience on Demand, was reviewed by The New York Times, The Wall Street Journal, The Washington Post, Nature, and The Times of London, and was an Amazon Best-seller.

    He has written opinion pieces for The Washington Post, The Wall Street Journal, Harvard Business Review, CNN, PBS NewsHour, Wired, National Geographic, Slate, The San Francisco Chronicle, TechCrunch, and The Chronicle of Higher Education, and has produced or directed six Virtual Reality documentary experiences which were official selections at the Tribeca Film Festival. His lab has exhibited VR in hundreds of venues ranging from The Smithsonian to The Superbowl.

  • Michael Baiocchi

    Michael Baiocchi

    Associate Professor of Epidemiology and Population Health and, by courtesy, of Statistics and of Medicine (Stanford Prevention Research Center)
    On Partial Leave from 01/01/2026 To 12/01/2026

    BioProfessor Baiocchi is a PhD statistician in Stanford University's Epidemiology and Population Health Department. He thinks a lot about behavioral interventions and how to rigorously evaluate if and how they work. Methodologically, his work focuses on creating statistically rigorous methods for causal inference that are transparent and easy to critique. He designed -- and was the principle investigator for -- two large randomized studies of interventions to prevent sexual assault in the settlements of Nairobi, Kenya.

    Professor Baiocchi is an interventional statistician (i.e., grounded in both the creation and evaluation of interventions). The unifying idea in his research is that he brings rigorous, quantitative approaches to bear upon messy, real-world questions to better people's lives.

  • Julie Baker

    Julie Baker

    Professor of Genetics

    Current Research and Scholarly InterestsWe examine how cells communicate and function during fetal development. The work in my laboratory focuses on the establishment of specific cell fates using genomics to decipher interactions between chromatin and developmental signaling cascades, between genomes and rapidly evolving cell types, and between genomic copy number variation and gene expression. In recent years we have focused on the vastly understudied biology of the trophoblast lineage, particularly how this lineage evolved.

  • Karthik Balakrishnan, MD, MPH, FAAP, FACS

    Karthik Balakrishnan, MD, MPH, FAAP, FACS

    Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics

    Current Research and Scholarly InterestsDr. Balakrishnan's research focuses on innovative ways to improve and standardize treatments and measure outcomes in complex pediatric airway and aerodigestive conditions , as well as ways to reduce treatment costs and medical errors. By improving outcomes and reducing costs, he aims to improve the value of care, while also optimizing patient and caregiver experience during the care process.

  • Halleh Balch

    Halleh Balch

    Assistant Professor of Oceans and, by courtesy, of Electrical Engineering

    BioHalleh B. Balch is an experimental physicist and HHMI Hanna H. Gray Faculty Fellow at Stanford University. Her research broadly focuses on advancing imaging, spectroscopy, and nanophotonics with a focus on applications in oceanography and water sustainability. Halleh received her PhD in physics from the University of California Berkeley and her undergraduate degree from Swarthmore College in physics and literature. Halleh joined Stanford as an Assistant Professor in the Doerr School of Sustainability in August 2025.

  • Nicholas Bambos

    Nicholas Bambos

    Richard W. Weiland Professor in the School of Engineering and Professor of Electrical Engineering

    BioNick Bambos is R. Weiland Professor in the School of Engineering at Stanford University, having a joint appointment in the Department of Electrical Engineering and the Department of Management Science & Engineering. He has been the Fortinet Founders Department Chair of the Management Science & Engineering Department (2016 – 20).

    He heads the Computer Systems Performance Engineering Lab (Perf-Lab) at Stanford, comprised of doctoral students and industry visitors engaged in various research projects, and was the Director (1999 – 2005) of the Stanford Networking Research Center (a research project of about $30M). He has published over 300 peer-reviewed research publications and graduated over 40 doctoral students (including two post-doctoral ones), who have moved on to leadership positions in academia, the Silicon Valley industries and technology startups, finance and venture capital, etc.

    His research interests are in architecture and high-performance engineering of computer systems and networks, as well as data analytics with an emphasis on medical and health-care analytics. His research contributions span the areas of networking and the Internet, cloud computing and data centers, multimedia streaming, computer security, digital health, etc. His methodological interests and contributions span the areas of network control, online task scheduling, routing and distributed processing, machine learning and artificial intelligence, etc.

    He received his Ph.D. (1989) in Electrical Engineering & Computer Sciences from the University of California at Berkeley. Before joining Stanford in 1996, he served as assistant professor (1989 – 95) and tenured associate professor (1995 – 96) of Electrical Engineering at the University of California at Los Angeles (UCLA).

    He has received several best research paper awards and has been the Cisco Systems Faculty Development Chair and the David Morgenthaler Faculty Scholar at Stanford. He has won the IBM Faculty Award, as well as the National Young Investigator Award and the Research Initiation Award from the National Science Foundation. He has been a Berkeley U.C. Regents Fellow, an E. C. Anthony Fellow, and a D. & S. Gale Fellow.

    He has served on various editorial boards of research journals, scientific boards of research labs, international technical and scientific committees, and technical review panels for networking and computing technologies. He has also served on corporate technical boards, as consultant and co-founder of technology start-up companies, and as expert witness in high-profile patent litigation and other legal cases involving information technologies.

  • Niaz Banaei

    Niaz Banaei

    Professor of Pathology and of Medicine (Infectious Diseases)

    Current Research and Scholarly InterestsHis research interests include (1) development, assessment, and improvement of novel infectious diseases diagnostics, (2) enhancing the quality of C. difficile diagnostic results, and (3) characterization of M. tuberculosis virulence determinants.

  • Steven Banik

    Steven Banik

    Assistant Professor of Chemistry

    BioSteven Banik’s research interests center on rewiring mammalian biology and chemical biotechnology development using molecular design and construction. Projects in the Banik lab combine chemical biology, organic chemistry, protein engineering, cell and molecular biology to precisely manipulate the biological machines present in mammalian cells. Projects broadly aim to perform new functions that shed light on regulatory machinery and the potential scope of mammalian biology. A particular focus is the study of biological mechanisms that can be coopted by synthetic molecules (both small molecules and proteins). These concepts are applied to develop new therapeutic strategies for treating aging-related disorders, genetic diseases, and cancer.

    Prior to joining the faculty at Stanford, Steven was a NIH and Burroughs CASI postdoctoral fellow advised by Prof. Carolyn Bertozzi at Stanford. His postdoctoral research developed approaches for targeted protein degradation from the extracellular space with lysosome targeting chimeras (LYTACs). He received his Ph.D. from Harvard University in 2016, where he worked with Prof. Eric Jacobsen on synthetic methods for the selective, catalytic difluorination of organic molecules and new approaches for generating and controlling reactive cationic intermediates in asymmetric catalysis.

  • Zhenan Bao

    Zhenan Bao

    K. K. Lee Professor, Senior Fellow at the Precourt Institute for Energy and Professor, by courtesy, of Materials Science and Engineering, of Chemistry, and of Bioengineering

    BioZhenan Bao joined Stanford University in 2004. She is currently a K.K. Lee Professor in Chemical Engineering, and with courtesy appointments in Chemistry, Bioengineering and Material Science and Engineering. She was the Department Chair of Chemical Engineering from 2018-2022 and in 2025. She founded the Stanford Wearable Electronics Initiative (eWEAR) and is the current faculty director. Bao received her Ph.D. degree in Chemistry from The University of Chicago in 1995 and joined Bell Labs, Lucent Technologies. She became a Distinguished Member of Technical Staff in 2001. Professor Bao currently has more than 800 refereed publications and more than 80 US patents with a Google Scholar H-index 237.

    Bao is a member of the US National Academy of Sciences, National Academy of Engineering, the American Academy of Arts and Sciences and the National Academy of Inventors. Bao was elected a foreign member of the Chinese Academy of Science in 2021. She is a Fellow of AAAS, ACS, MRS, SPIE, ACS POLY and ACS PMSE.

    Bao is a member of the Board of Directors for the Camille and Dreyfus Foundation from 2022. She served as a member of Executive Board of Directors for the Materials Research Society and Executive Committee Member for the Polymer Materials Science and Engineering division of the American Chemical Society. She co-founded C3 Nano Co. (acquired by Du Pont) and PyrAmes, which have produced products used in commercial smartphones and hospitals, respectively. Multiple inventions from her lab have been licensed and served as foundational technologies for several additional start-ups.

    Bao was a recipient of the VinFuture Prize Female Innovator 2022, ACS Award of Chemistry of Materials 2022, MRS Mid-Career Award in 2021, AICHE Alpha Chi Sigma Award 2021, ACS Central Science Disruptor and Innovator Prize in 2020, ACS Gibbs Medal in 2020, the Wilhelm Exner Medal from the Austrian Federal Minister of Science in 2018, the L'Oreal UNESCO Women in Science Award North America Laureate in 2017. She was awarded the ACS Applied Polymer Science Award in 2017, ACS Creative Polymer Chemistry Award in 2013 ACS Cope Scholar Award in 2011. She is a recipient of the Royal Society of Chemistry Beilby Medal and Prize in 2009, IUPAC Creativity in Applied Polymer Science Prize in 2008.

    In Stanford, Bao has pioneered molecular design concepts and fabrication processes to advance the scope and applications of skin-inspired electronics. Her group discovered nano confinement effect of conjugated polymers in polymer blends, which established the fundamental foundation for skin-inspired electronic materials and devices. Her work has resulted in new materials and device solutions for soft robotics, wearable and implantable electronics for precision health, precision mental health and advanced tools for understanding neuroscience and treatment of neurodegenerative diseases. Building on chemical insights, her group has developed foundational materials and devices that enabled a new generation of skin-inspired soft electronics. They provide unprecedented opportunities for understanding human health through developing monitoring, diagnosis and treatment tools. Some examples include: a neuromorphic e-skin that can sense force and temperature and directly communicate with brain, a wireless wound healing patch, a soft NeuroString for simultaneous neurochemical monitoring in the brain and gut, soft high-density electrophysiological recording array, a meta-learned skin sensor for detailed body movements, a reconfigurable self-healing electronic skin.

  • Maria Barna

    Maria Barna

    Associate Professor of Genetics

    Current Research and Scholarly InterestsOur lab studies how intricate control of gene expression and cell signaling is regulated on a minute-by-minute basis to give rise to the remarkable diversity of cell types and tissue morphology that form the living blueprints of developing organisms. Work in the Barna lab is presently split into two main research efforts. The first is investigating ribosome-mediated control of gene expression genome-wide in space and time during cellular differentiation and organismal development. This research is opening a new field of study in which we apply sophisticated mass spectrometry, computational biology, genomics, and developmental genetics, to characterize a ribosome code to gene expression. Our research has shown that not all of the millions of ribosomes within a cell are the same and that ribosome heterogeneity can diversify how genomes are translated into proteomes. In particular, we seek to address whether fundamental aspects of gene regulation are controlled by ribosomes harboring a unique activity or composition that are tuned to translating specific transcripts by virtue of RNA regulatory elements embedded within their 5’UTRs. The second research effort is centered on employing state-of-the-art live cell imaging to visualize cell signaling and cellular control of organogenesis. This research has led to the realization of a novel means of cell-cell communication dependent on a dense network of actin-based cellular extension within developing organs that interconnect and facilitate the precise transmission of molecular information between cells. We apply and create bioengineering tools to manipulate such cellular interactions and signaling in-vivo.

  • Christopher O. Barnes

    Christopher O. Barnes

    Assistant Professor of Biology and, by courtesy, of Structural Biology

    Current Research and Scholarly InterestsResearch in our lab is aimed at defining the structural correlates of broad and potent antibody-mediated neutralization of viruses. We combine biophysical and structural methods (e.g., cryo-EM), protein engineering, and in vivo approaches to understand how enveloped viruses infect host cells and elicit antigen-specific immune responses. We are particularly interested in the co-evolution of HIV-1 and broadly-neutralizing IgG antibodies (bNAbs), which may hold the key to the development of an effective HIV-1 vaccine. In addition, we are investigating antibody responses to SARS-CoV-2 and related zoonotic coronaviruses (CoV), with the related goal of developing broadly-protective immunotherapies and vaccines against variants of concern and emerging CoV threats.

    HIV-1; SARS-CoV-2; coronaviruses; cryo-EM; crystallography; vaccines; directed evolution

  • Annelise E. Barron

    Annelise E. Barron

    Associate Professor of Bioengineering

    Current Research and Scholarly InterestsBiophysical mechanisms of host defense peptides (a.k.a. antimicrobial peptides) and their peptoid mimics; also, molecular and cellular biophysics of human innate immune responses.

  • Greg Barsh

    Greg Barsh

    Professor of Genetics and of Pediatrics, Emeritus

    Current Research and Scholarly InterestsGenetics of color variation

  • Michael Bassik

    Michael Bassik

    Associate Professor of Genetics

    Current Research and Scholarly InterestsWe are an interdisciplinary lab focused on two major areas:(1) we seek to understand mechanisms of cancer growth and drug resistance in order to find new therapeutic targets(2) we study mechanisms by which macrophages and other cells take up diverse materials by endocytosis and phagocytosis; these substrates range from bacteria, viruses, and cancer cells to drugs and protein toxins. To accomplish these goals, we develop and use new technologies for high-throughput functional genomics.

  • Glaivy Batsuli, MD

    Glaivy Batsuli, MD

    Associate Professor of Pediatrics (Hematology/Oncology)

    Current Research and Scholarly InterestsHemophilia is a rare inherited X-linked bleeding disorder characterized by the deficiency of blood clotting proteins factor VIII or factor IX. These individuals are at risk for spontaneous bleeds and trauma or surgery-induced bleeding. There have been remarkable advancements in the management of hemophilia to prevent these bleeding episodes and improve quality of life. However, the presence of neutralizing antibodies, called inhibitors, still dictates access to novel therapies such as factor replacement for bleed management and now FDA-approved gene therapies. The Batsuli Lab is focused on elucidating mechanisms of the immune response to blood coagulation proteins in bleeding disorders in order to develop strategies and therapeutics for inhibitor prevention and tolerance induction.

    Dr. Batsuli's clinical research interests also include clinical trial participation for novel therapeutics & interventions in bleeding disorders such as hemophilia and von Willebrand disease in addition to coagulation issues & outcomes in ultra-rare bleeding disorders and sickle cell disease.

  • Fiona Baumer

    Fiona Baumer

    Assistant Professor of Neurology (Pediatric Neurology)

    Current Research and Scholarly InterestsCauses of Disturbed Cognition in Pediatric Epilepsy

  • Mohsen Bayati

    Mohsen Bayati

    Carl and Marilynn Thoma Professor in the Graduate School of Business and Professor, by courtesy, of Electrical Engineering and of Radiation Oncology (Radiation Therapy)

    Current Research and Scholarly Interests1) Healthcare management: I am interested in improving healthcare delivery using data-driven modeling and decision-making.

    2) Network models and message-passing algorithms: I work on graphical modeling ideas motivated from statistical physics and their applications in statistical inference.

    3) Personalized decision-making: I work on machine learning and statistical challenges of personalized decision-making. The problems that I have worked on are primarily motivated by healthcare applications.

  • Tina Baykaner

    Tina Baykaner

    Assistant Professor of Medicine (Cardiovascular Medicine)

    BioTina Baykaner, MD, MPH is an Assistant Professor of Medicine in the Division of Cardiovascular Medicine and Cardiac Electrophysiology at Stanford University School of Medicine. She completed residency and fellowships in cardiovascular medicine and advanced heart failure at the University of California, San Diego, followed by fellowship training in cardiac electrophysiology at Stanford. She joined the Stanford faculty in 2018 and was promoted to Assistant Professor in 2023.

    Dr. Baykaner’s research program focuses on atrial fibrillation (AF), cardio-oncology, and the integration of artificial intelligence and machine learning into cardiac electrophysiology. She is Principal Investigator of an NIH R01 investigating atrial fibrillation in patients with hematologic malignancies treated with tyrosine kinase inhibitors and previously led an NIH K23 award focused on personalizing AF management using machine learning. She also serves as co-investigator or consultant on multiple NIH-funded R01 projects in artificial intelligence, ventricular arrhythmias, and digital cardiovascular phenotyping. Her work spans AF mechanisms, ablation outcomes, digital health implementation, and equity in arrhythmia care.

    She has authored over 200 peer-reviewed publications, book chapters, and abstracts, including more than 100 original research manuscripts, and has delivered over 100 invited lectures nationally and internationally. She served as a task force member for the 2024 EHRA/HRS/APHRS/LAHRS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation and holds editorial leadership roles, including Associate Editor for the Journal of Interventional Cardiac Electrophysiology and editorial board positions with multiple electrophysiology journals.

    Dr. Baykaner is Vice-Chair of the Heart Rhythm Society Digital Education Committee and serves on national program and grant review committees, including NIH/NHLBI study sections. She is actively engaged in mentorship across undergraduate, medical, graduate, and postdoctoral levels, with mentees who have received national awards and progressed to electrophysiology fellowship and faculty positions.

    Her clinical practice focuses on catheter ablation of atrial and ventricular arrhythmias, supraventricular tachycardias, management of inappropriate sinus tachycardia, cardiac implantable electronic device implantation and extraction, and advanced rhythm management strategies in complex patient populations.

  • Philip Beachy

    Philip Beachy

    The Ernest and Amelia Gallo Professor, Professor of Urology, of Developmental Biology and, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly InterestsFunction of Hedgehog proteins and other extracellular signals in morphogenesis (pattern formation), in injury repair and regeneration (pattern maintenance). We study how the distribution of such signals is regulated in tissues, how cells perceive and respond to distinct concentrations of signals, and how such signaling pathways arose in evolution. We also study the normal roles of such signals in stem-cell physiology and their abnormal roles in the formation and expansion of cancer stem cells.

  • Christopher Beaulieu M.D., Ph.D.

    Christopher Beaulieu M.D., Ph.D.

    Professor of Radiology (Musculoskeletal Imaging)
    On Partial Leave from 01/05/2026 To 06/26/2026

    Current Research and Scholarly InterestsInformatics and image processing techniques that provide infrastructure for diagnosis in musculoskeletal imaging. Decision support for improving accuracy of bone tumor diagnosis. Improved methods for MRI in the musculoskeletal system.

  • Barry Behr, Ph.D., H.C.L.D.

    Barry Behr, Ph.D., H.C.L.D.

    Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility), Emeritus

    Current Research and Scholarly InterestsDevelopment of improved embryo culture conditions in vitro. Blastocyst cultures. Embryo metabolism in vitro. Embryo maternal dialogue. Clinical application and integration of extended embryo culture systems. Monozygotic twinning. Prevention of multiple pregnancy. Sperm motility enhancers. Fluorescent and non-fluorescent markers of sperm morphology and viablility. Oocyte cryopreservation. Fertility preservation. Improving IVF outcome.

  • Corinne Beinat

    Corinne Beinat

    Assistant Professor of Radiology (Molecular Imaging Program at Stanford)

    Current Research and Scholarly InterestsThe focus of my research is to develop novel imaging and treatment strategies to detect and better manage cancer. This approach relies first on the identification and validation of molecular targets and biomarkers that are linked with underlying the underlying biology driving the initiation and progression of cancers. We then develop novel small molecule based radiotracers to monitor fundamental molecular and cellular processes occurring in living subjects using positron emission tomography (PET) with the goal of improving cancer diagnosis and management. We additionally develop novel peptide based theragnostic agents for stratification of patients with high receptor expression, treatment with targeted radionuclide therapy, and subsequent monitoring of treatment response. Our overall goal is to develop multiple clinically translatable strategies to improve cancer diagnosis, management, and outcomes.

  • Gill Bejerano

    Gill Bejerano

    Professor of Developmental Biology, of Computer Science and of Pediatrics (Genetics)

    Current Research and Scholarly Interests1. Automating monogenic patient diagnosis.
    2. The genomic signatures of independent divergent and convergent trait evolution in mammals.
    3. The logic of human gene regulation.
    4. The reasons for sequence ultraconservation.
    5. Cryptogenomics to bridge medical silos.
    6. Cryptogenetics to debate social injustice.
    7. Managing patient risk using machine learning.
    8. Understanding the flow of money in the US healthcare system.

  • Sean Bendall

    Sean Bendall

    Associate Professor of Pathology
    On Partial Leave from 02/01/2026 To 10/31/2026

    Current Research and Scholarly InterestsOur goal is to understand the mechanisms regulating the development of human systems. Drawing on both pluripotent stem cell biology, hematopoiesis, and immunology, combined with novel high-content single-cell analysis (CyTOF – Mass Cytometry) and imagining (MIBI-Multiplexed Ion Beam Imaging) we are creating templates of ‘normal’ human cellular behavior to both discover novel regulatory events and cell populations as well as understand dysfunctional processes such as cancer.

  • Jade Benjamin-Chung

    Jade Benjamin-Chung

    Assistant Professor of Epidemiology and Population Health

    Current Research and Scholarly InterestsOur research aims to improve population health by creating high quality evidence about what health interventions work in whom and where, when, and how to implement them. Most of our research is focused on environmentally-mediated infectious diseases, including malaria, diarrhea, soil-transmitted helminths, and influenza. Our focus is on improving the health of vulnerable populations from low-resource settings, both domestically and internationally. We use a variety of epidemiologic, computational, and statistical methods, including causal inference and machine learning methods.

  • Christopher Bennett

    Christopher Bennett

    Asst Prof-Univ Med Line, Emergency Medicine

    BioI am a board-certified emergency physician and researcher at Stanford, where I bridge clinical practice with health innovation. In addition to being faculty in the Department of Emergency Medicine, I hold affiliations with the Stanford Institute for Human-Centered AI (HAI), the Center for AI in Medicine & Imaging (AIMI), and the Center for Digital Health (CDH).

    My work leverages data-informed precision medicine with the goal of transforming healthcare delivery—especially for transmissible infectious diseases. As an NIH funded investigator, I lead a research group that designs solutions to improve patient outcomes and inform policy. I bring extensive experience from training at Duke, Harvard, and Stanford, and a proven track record of leadership from serving on the Society for Academic Emergency Medicine (SAEM) Board of Directors, the SAEM Foundation Board of Trustees.

    I am passionate about collaboration to pioneer digital health strategies that revolutionize care and drive tangible impact.

  • Stacey Bent

    Stacey Bent

    Jagdeep & Roshni Singh Professor in the School of Eng, Professor of Energy Science and Eng, Senior Fellow at Precourt & Prof, by courtesy, of Electrical Eng, Materials Sci Eng & Chemistry
    On Leave from 04/01/2025

    BioThe research in the Bent laboratory is focused on understanding and controlling surface and interfacial chemistry and applying this knowledge to a range of problems in semiconductor processing, micro- and nano-electronics, nanotechnology, and sustainable and renewable energy. Much of the research aims to develop a molecular-level understanding in these systems, and hence the group uses of a variety of molecular probes. Systems currently under study in the group include functionalization of semiconductor surfaces, mechanisms and control of atomic layer deposition, molecular layer deposition, nanoscale materials for light absorption, interface engineering in photovoltaics, catalyst and electrocatalyst deposition.

  • Jonathan S. Berek, MD, MMSc

    Jonathan S. Berek, MD, MMSc

    Laurie Kraus Lacob Professor

    BioLaurie Kraus Lacob Professor
    Stanford University School of Medicine

    Founding Director, Stanford Women’s Cancer Center

    Senior Advisor, Stanford Cancer Institute

    Co-Chair, Senior Academy at Stanford Medicine

    President, Stanford University Phi Beta Kappa

    Director, MedArts Films

    Faculty Director, Health Communication
    Stanford Center for Health Education

    A Stanford faculty member since 2005, Professor Berek is renowned for his many contributions to and expertise in gynecologic oncology, especially surgical innovation and techniques, and his research in immunology and immunotherapy. Through many laboratory and clinical investigations, he pioneered the use of regionally-administered immunotherapy in ovarian cancer patients. His early laboratory research focused on fundamental mechanisms of cancer immunology, elucidating growth regulatory pathways for cytokines and their receptors. His current research focuses on clinical trials of novel therapies and immunotherapies for ovarian cancer and collaborations on new diagnostics, screening techniques, and genetics.

    An author and editor, Professor Berek has published more than 360 peer-reviewed manuscripts in the scientific literature, and numerous book chapters and monographs. His books, Berek & Hacker’s Gynecologic Oncology, now in its 7th edition, and Berek & Novak’s Gynecology, in its 17th edition, are leading texts in the field. He is the Series Editor for Operative Techniques in Gynecologic Surgery, for which five textbooks on various subspecialty topics in Obstetrics and Gynecology have been published. He serves as the Editor-in-Chief for Current Opinion in Obstetrics & Gynecology, and he is a former Editor-in-Chief of ASCO Connection, published by the American Society of Clinical Oncology.

    Professor Berek received his Bachelor of Arts degree in English Literature and Theatre Arts, and a Master of Medical Sciences degree in biomedical sciences from Brown University. After earning his Doctor of Medicine from Johns Hopkins University School of Medicine, he completed an internship and residency at Harvard Medical School, Brigham & Women’s Hospital. Before moving to Stanford, he was on the faculty at the UCLA School of Medicine for more than two decades.

    Professor Berek has received many honors and accolades. Dr. Berek is the 2019 Lifetime Achievement Honoree of the American Cancer Society for his many accomplishments in women’s cancer treatment and research. In 2022, he received a Lifetime Achievement Award from the International Society of Gynecologic Cancer for his contributions to the field of gynecologic oncology.

    In addition to his medical career, Professor Berek is an active documentary filmmaker—creating and directing films on a variety of medical topics that are highlighted by patient stories. He is the Director and Producer of MedArts Films https://vimeo.com/medarts/videos. He directed a series of films for the Stanford Office of Medical Development, and many short films for the Stanford Center for Health Education that are found on YouTube at the Stanford Medicine Health Shelf. https://www.youtube.com/@Stanford_CHE/playlists

    In collaboration with the Under One Umbrella Committee and Stanford Medical Center Development, Professor Berek has led a highly successful fundraising program for the Stanford Women’s Cancer Center. Since 2009, these Under One Umbrella philanthropy efforts have generated substantial support for innovative research programs in women’s cancer via concerts headlined by celebrities, including Nicole Kidman, Keith Urban, Trisha Yearwood, Garth Brooks, Tom Hanks, Rita Wilson, Carrie Underwood, Sheryl Crow, Vince Gill, Amy Grant, Darlene Love, and Harry Connick Jr.
    https://www.facebook.com/StanfordWomensCancerCenter/

  • Jonathan Berger

    Jonathan Berger

    Denning Family Provostial Professor

    BioJonathan Berger is the Denning Family Provostial Professor in Music at Stanford University, where he teaches composition, music theory, and cognition, and directs the Center for Computer Research in Music and Acoustics (CCRMA).
    Jonathan is a 2017 Guggenheim Fellow and a 2016 winner of the Rome Prize.
    He was the founding co-director of the Stanford Institute for Creativity and the Arts (SICA, now the Stanford Arts Institute) and founding director of Yale University’s Center for Studies in Music Technology
    Described as “gripping” by both the New York Times and the Chicago Tribune, “poignant”, “richly evocative” (San Francisco Chronicle), “taut, and hauntingly beautiful” (NY Times), Jonathan Berger’s recent works deal with both consciousness and conscience. His monodrama, My Lai, toured internationally. The Kronos Quartet's recording was released by Smithsonian/Folkways. His opera, The Ritual of Breath is the Rite to Resist was performed at Lincoln Center in July 2024. Other recent premiers include Hajar Yasini for narrator, string quartet and video (premiered by the Kronos Quartet), and Mekong:Soul (co-composed with Van Anh Vo) which was performed at the Kennedy Center and in Houston.
    Thrice commissioned by The National Endowment for the Arts, Berger’a recent commissions include The Mellon and Rockefeller Foundations, Chamber Music Society, Lincoln Center, and Chamber Music America.

    In addition to composition, Berger is an active researcher with over 80 publications in a wide range of fields relating to music, science and technology and has held research grants from DARPA, the Wallenberg Foundation, The National Academy of Sciences, the Keck Foundation, and others.
    Berger is the PI of a major grant from the Templeton Religion Trust to study how music and architecture interact to create a sense of awe.

  • Miles Berger

    Miles Berger

    Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)

    BioI am a neuroanesthesiologist and translational human neuroscientist. Clinically, I care for patients undergoing brain and spine surgery, and have an interest in optimizing anesthesia care (and postoperative cognitive outcomes) for older surgical patients.
    My research team studies mechanisms of perioperative neurocognitive disorders (such as delirium) in older adults, the relationship between anesthetic brain sensitivity (as measured by EEG) and preclinical/prodromal age-related changes in brain structure and function, and mechanisms by which the APOE4 allele leads to increased Alzheimer's Disease risk and neurocognitive decline. Together with collaborators, we use a transdisciplinary approach combining molecular/cellular assays (including ELISAs, proteomics, metabolomics, and flow cytometry) on pre- and post-operative CSF and plasma samples from older surgical surgical patients, functional and structural MRI neuroimaging, pre- and intra-operative EEG recordings, genetics (and epigenetics), and pre and postoperative delirium screening and cognitive testing. Overall, our hope is that the combination of these different methods will allow us to obtain insights into the mechanisms of perioperative neurocognitive disorders that could not be obtained by any single method alone.
    Our group values mentorship, and we are happy to talk with prospective undergraduate, graduate or post-doctoral students with an interest in our work.

  • Dominique Bergmann

    Dominique Bergmann

    Shirley R. and Leonard W. Ely, Jr. Professor of the School of Humanities and Sciences

    Current Research and Scholarly InterestsWe use genetic, genomic and cell biological approaches to study cell fate acquisition, focusing on cases where cell fate is correlated with asymmetric cell division.

  • Daniel Bernstein

    Daniel Bernstein

    Alfred Woodley Salter and Mabel G. Salter Endowed Professor of Pediatrics

    Current Research and Scholarly Interests1. Using iPSC-derived cardiomyocytes to understand hypertrophic cardiomyopathy and heart failure associated with congenital heart disease.
    2. Role of alterations in mitochondrial dycamics and function in normal physiology and disease.
    3. Differences between R and L ventricular responses to stress,
    4. Immune biomarkers of risk after pediatric VAD implantation.
    5. Biomarkers for post-transplant lymphoproliferative disorder.

  • Jon Bernstein

    Jon Bernstein

    Professor of Pediatrics (Genetics) and, by courtesy, of Genetics

    Current Research and Scholarly InterestsMy research is focused on the diagnosis, discovery and delineation of rare genetic conditions with a focus on neurodevelopmental disorders. This work includes the application of novel computational methods and multi-omics profiling (whole genome sequencing, long-read DNA sequencing, RNA sequencing, methylomics, metabolomics). I additionally participate in an interdisciplinary project to develop induced pluripotent stem cell and assembloid models of genetic neurodevelopmental disorders.

  • Michael Bernstein

    Michael Bernstein

    Professor of Computer Science and Senior Fellow at the Stanford Institute for Human-Centered AI

    BioMichael Bernstein is a Professor of Computer Science at Stanford University, where he is a Bass University Fellow and Senior Fellow at the Stanford Institute for Human-Centered Artificial Intelligence. A nationally bestselling author, Michael focuses on designing social, societal, and interactive technologies. This research has been reported in venues such as The New York Times, TED AI, and MIT Technology Review, and Michael himself has been recognized with an Alfred P. Sloan Fellowship and the Computer History Museum's Tech for Humanity Prize. Michael holds a bachelor's degree in Symbolic Systems from Stanford University, as well as a master's degree and a Ph.D. in Computer Science from MIT.

  • Mark Francis Berry, MD

    Mark Francis Berry, MD

    Mylavarapu Rogers Professor of Cardiothoracic Surgery

    BioDr. Berry joined the Division of Thoracic Surgery at Stanford in August 2014. He came to Stanford from Duke University, where he had most recently served as Associate Professor. He received his medical degree at the University of Pennsylvania School of Medicine after receiving bachelors and masters degrees in Electrical Engineering at the University of Pennsylvania. He completed his residency in Cardiothoracic Surgery at Duke University Medical Center after performing a residency in General Surgery at the Hospital of the University of Pennsylvania. His Cardiothoracic Surgical training included a year dedicated to Minimally Invasive General Thoracic Surgery, a period that also included an American Association for Thoracic Surgery sponsored Traveling Fellowship at the University of Pittsburgh.

    Dr. Berry practices all aspects of thoracic surgery, including procedures for benign and malignant conditions of the lung, esophagus, and mediastinum. He has a particular interest in minimally invasive techniques, and has extensive experience in treating thoracic surgical conditions using video-assisted thoracoscopic surgical (VATS), laparoscopic, robotic, endoscopic, and bronchoscopic approaches. He serves as the co-Director of the Stanford Minimally Invasive Thoracic Surgery Center (SMITS), and has both directed and taught in several minimally invasive thoracic surgery courses.

    Dr. Berry also has a Masters of Health Sciences in Clinical Research from Duke University. His clinical research activities mirror his clinical interests and activities in optimizing short-term and long-term outcomes of patients with thoracic surgical conditions. He has more than 150 peer-reviewed publications, most of which are related to both the use of minimally invasive thoracic surgical techniques as well as evaluating outcomes after treatment of thoracic malignancies. His clinical practice and his research both focus on choosing the most appropriate treatment and approach for patients based on the individual characteristics of the patient and their disease process.

  • Edward Bertaccini

    Edward Bertaccini

    Professor of Anesthesiology, Perioperative and Pain Medicine (MSD), Emeritus

    Current Research and Scholarly Interestsmolecular modeling of anesthetic-protein interactions, molecular modeling of the ligand-gated ion channels

  • Alice Bertaina MD, PhD

    Alice Bertaina MD, PhD

    Lorry I. Lokey Professor

    Current Research and Scholarly InterestsDr. Bertaina is a highly experienced clinician and will play a key role in supporting Section Chief Dr. Rajni Agarwal and Clinical Staff in the Stem Cell Transplant Unit at Lucile Packard Children’s Hospital. She will also continue her research on immune recovery and miRNA, understanding the mechanisms underlying immune reconstitution, Graft-versus-Host Disease (GvHD), and leukemia relapse after allogeneic HSCT in pediatric patients affected by hematological malignant and non-malignant disorders.

  • Carolyn Bertozzi

    Carolyn Bertozzi

    Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology

    BioCarolyn Bertozzi is the Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology and of Radiology at Stanford University, and an Investigator of the Howard Hughes Medical Institute. She completed her undergraduate degree in Chemistry from Harvard University in 1988 and her Ph.D. in Chemistry from UC Berkeley in 1993. After completing postdoctoral work at UCSF in the field of cellular immunology, she joined the UC Berkeley faculty in 1996. In June 2015, she joined the faculty at Stanford University and became the co-director and Institute Scholar at Sarafan ChEM-H.

    Prof. Bertozzi's research interests span the disciplines of chemistry and biology with an emphasis on studies of cell surface glycosylation pertinent to disease states. Her lab focuses on profiling changes in cell surface glycosylation associated with cancer, inflammation and bacterial infection, and exploiting this information for development of diagnostic and therapeutic approaches, most recently in the area of immuno-oncology.

    Prof. Bertozzi has been recognized with many honors and awards for both her research and teaching accomplishments. She is an elected member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the German Academy of Sciences Leopoldina. Some awards of note include the Nobel Prize in Chemistry, Lemelson-MIT award for inventors, Whistler Award, Ernst Schering Prize, MacArthur Foundation Fellowship, the ACS Award in Pure Chemistry, Tetrahedron Young Investigator Award, and Irving Sigal Young Investigator Award of the Protein Society. Her efforts in undergraduate education have earned her the UC Berkeley Distinguished Teaching Award and the Donald Sterling Noyce Prize for Excellence in Undergraduate Teaching.

  • Vivek Bhalla, MD

    Vivek Bhalla, MD

    Associate Professor of Medicine (Nephrology)

    Current Research and Scholarly InterestsDr. Bhalla's two primary research interests are in the role of the kidney in diabetes and hypertension. We use molecular, biochemical, and transgenic approaches to study: (1) mechanisms diabetic kidney disease disease including the role of the endothelium to regulate inflammation and kidney injury; and (2) regulation of tubular transport of glucose, sodium, and potassium. These latter studies have treatment implications in diabetes, kidney disease, and hypertension.

  • Ami Bhatt

    Ami Bhatt

    Professor of Medicine (Hematology) and of Genetics

    Current Research and Scholarly InterestsThe Bhatt lab is exploring how the microbiota is intertwined with states of health and disease. We apply the most modern genetic tools in an effort to deconvolute the mechanism of human diseases.

  • Nidhi Bhutani

    Nidhi Bhutani

    Associate Professor of Orthopaedic Surgery

    Current Research and Scholarly InterestsThe long-term goal of our research is to understand the fundamental mechanisms that govern and reprogram cellular fate during development, regeneration and disease.

  • Lacramioara Bintu

    Lacramioara Bintu

    Associate Professor of Bioengineering

    BioLacra Bintu is an Associate Professor of Bioengineering and a member of the Biophysics Program and Bio-X Institute at Stanford University. She earned undergraduate degrees in Physics, Mathematics, and Neuroscience from Brandeis University. As an undergraduate working with Jane Kondev and Rob Phillips, she used statistical mechanics to model transcription factor binding and gene regulation. She completed her Physics Ph.D. at U.C. Berkeley with Carlos Bustamante, where she used single-molecule approaches to study transcription on nucleosomal templates. As a postdoctoral scholar at Caltech with Michael Elowitz, she used live-cell microscopy to investigate chromatin-mediated gene regulation.

    Her group seeks to discover fundamental principles of gene regulation and advance mammalian synthetic biology, with an emphasis on causal mechanisms, dynamic responses, and single-cell variability that enable signal integration at the population level. The lab develops tools to manipulate gene expression, for example by recruiting chromatin, transcriptional, or RNA regulators to defined genomic loci, or building DNA regulatory elements such as signal-responsive enhancers or silencers. To assess gene regulation responses at scale, the lab is using and developing new sequencing and imaging based techniques such as: delivery of large DNA libraries to cells coupled with sorting based on fluorescent and magnetic reporters, time-lapse fluorescence microscopy and in situ sequencing, or single-molecule footprinting of transcription factors and nucleosomes binding in live cells. Her group uses mathematical modeling to capture the fundamental principles underlying the observed gene expression responses and to predict new behaviors. This work provides insight into epigenetic mechanisms underlying development, cancer, and immune function and informs strategies for gene therapies that correct aberrant expression states.

    Lacra lives in Menlo Park with her husband Anton and son Manu. They enjoy hiking, cooking, reading, playing board games, and watching birds in their backyard with their two cats.

  • Biondo Biondi

    Biondo Biondi

    Barney and Estelle Morris Professor

    Current Research and Scholarly InterestsResearch
    My students and I devise new algorithms to improve the imaging of reflection seismic data. Images obtained from seismic data are the main source of information on the structural and stratigraphic complexities in Earth's subsurface. These images are constructed by processing seismic wavefields recorded at the surface of Earth and generated by either active-source experiments (reflection data), or by far-away earthquakes (teleseismic data). The high-resolution and fidelity of 3-D reflection-seismic images enables oil companies to drill with high accuracy for hydrocarbon reservoirs that are buried under two kilometers of water and up to 15 kilometers of sediments and hard rock. To achieve this technological feat, the recorded data must be processed employing advanced mathematical algorithms that harness the power of huge computational resources. To demonstrate the advantages of our new methods, we process 3D field data on our parallel cluster running several hundreds of processors.

    Teaching
    I teach a course on seismic imaging for graduate students in geophysics and in the other departments of the School of Earth Sciences. I run a research graduate seminar every quarter of the year. This year I will be teaching a one-day short course in 30 cities around the world as the SEG/EAGE Distinguished Instructor Short Course, the most important educational outreach program of these two societies.

    Professional Activities
    2007 SEG/EAGE Distinguished Instructor Short Course (2007); co-director, Stanford Exploration Project (1998-present); founding member, Editorial Board of SIAM Journal on Imaging Sciences (2007-present); member, SEG Research Committee (1996-present); chairman, SEG/EAGE Summer Research Workshop (2006)

  • Julius Bishop, MD

    Julius Bishop, MD

    Associate Professor of Orthopaedic Surgery

    Current Research and Scholarly InterestsDr. Bishop specializes in treating fractures of the upper extremity, lower extremity, pelvis and acetabulum as well as the management of post-traumatic problems including malunion, nonunion and infection.

    He received his undergraduate and medical school degrees from Harvard University and went on to complete the Harvard Combined Orthopaedic Surgery Residency Program. He pursued his subspecialty training in Orthopaedic Traumatology at the world-renowned Harborview Medical Center in Seattle, Washington.

    His research interests include applying decision analysis models to orthopaedic trauma problems, studying clinical outcomes after musculoskeletal injury, orthopaedic biomechanics, the basic science of fracture healing, and evaluating new strategies and techniques in fracture surgery.

  • Helen M. Blau

    Helen M. Blau

    Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsProf. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.

  • Nikolas Blevins, MD

    Nikolas Blevins, MD

    Larry and Sharon Malcolmson Professor in the School of Medicine, Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsInner ear microendoscopy -- Developing techniques for minimally-invasive imaging of inner ear microanatomy and neural pysiology. Applications include improved cochlear implant development, inner ear regenerative techniques, inner ear surgery, and auditory physiology.

    Microsurgical robotics -- Developing scalable microsurgical instrumentation and robotic techniques for use in head and neck surgery.

    Surgical Simulation -- Immersive environment for temporal bone surgical simulation.

  • Catherine Blish

    Catherine Blish

    George E. and Lucy Becker Professor in Medicine

    Current Research and Scholarly InterestsThe major goal of our research is to gain insight into the prevention and control of HIV and other viral pathogens by studying the interplay between the virus and the host immune response. We investigate the role of various arms of the immune response, but with a particular focus on NK cells. We hope to gain additional insights into control of infectious diseases by studying how pregnancy modulates immune responses.

  • Barbara Block

    Barbara Block

    Charles and Elizabeth Prothro Professor of Marine Sciences, Professor of Oceans and Senior Fellow at the Woods Institute for the Environment

    Current Research and Scholarly InterestsThermal physiology, open ocean predators, ecological physiology and tuna biology

  • Steven M. Block

    Steven M. Block

    The Stanford W. Ascherman, M.D., Professor and Professor of Applied Physics and of Biology, Emeritus

    Current Research and Scholarly InterestsSingle molecule biophysics using optical trapping and fluorescence

  • Yair Blumenfeld, MD

    Yair Blumenfeld, MD

    Professor of Obstetrics and Gynecology (Maternal Fetal Medicine)
    On Partial Leave from 02/15/2026 To 03/15/2026

    Current Research and Scholarly Interestsprenatal diagnosis, genetics, clinical obstetrics

  • Mark S. Blumenkranz, MD, MMS

    Mark S. Blumenkranz, MD, MMS

    H. J. Smead Professor of Ophthalmology, Emeritus

    Current Research and Scholarly InterestsClinical Interest and Research
    My primary areas of interest are in the diagnosis, medical and surgical treatment of vitreal retinal diseases. These principally include age-related macular degeneration and other diseases of the macula, and tractional syndromes, diabetic retinopathy, and complex forms of retinal detachment. I have been interested in the development of novel technology to diagnose and treat these diseases, including new forms of imaging, laser delivery systems, other microsurgical tools, and new drugs and drug delivery systems that inhibit new blood vessel growth, scarring and intraocular inflammation. I have been actively involved in translational research in the laboratory as well as technology transfer associated with that research for a variety of new therapies that have received FDA clearance and been introduced into clinical practice over the past 30 years.

    Administrative and Community Service
    I have served on the Board of Directors of a variety of voluntary education and service organizations, including the Corporation of Brown University, multiple scientific advisory boards and various philanthropic and research organizations.

  • Fernando E Boada

    Fernando E Boada

    Professor of Radiology (Radiological Sciences Laboratory)

    BioFernando Boada is a Professor of Radiology and Associate Chair for Basic Science Translational Research at Stanford University Medical School. [1] He joined Stanford in 2021 after being Professor of Radiology, Psychiatry and Neurosurgery at New York University Medical School and the Director of the Center for Advanced Imaging Innovation and Research. [1] Prior to joining NYU in 2012, Dr. Boada directed the MR Research Center (MRRC) at the University of Pittsburgh for ten years. [1] His research efforts have been focused on the development of novel MRI techniques for addressing open neuroimaging questions in a translational setting.

  • Kwabena Boahen

    Kwabena Boahen

    Professor of Bioengineering and of Electrical Engineering

    Current Research and Scholarly InterestsBoahen's group analyzes neural behavior computationally to elucidate principles of neural design at the cellular, circuit, and systems levels; and synthesizes neuromorphic electronic systems that scale energy-use with size as efficiently as the brain does. This interdisciplinary research program bridges neurobiology and medicine with electronics and computer science, bringing together these seemingly disparate fields.

  • Alexandria Boehm

    Alexandria Boehm

    Richard and Rhoda Goldman Professor of Environmental Studies, Professor of Oceans and Senior Fellow at the Woods Institute for the Environment

    BioI am interested in pathogens in the environment including their sources, fate, and transport in natural and engineered systems. I am interested in understanding of how pathogens are transmitted to humans through contact with water, feces, and contaminated surfaces. My research is focused on key problems in both developed and developing countries with the overarching goal of designing and testing novel interventions and technologies for reducing the burden of disease.

    I am also interested broadly in coastal water quality where my work addresses the sources, transformation, transport, and ecology of biocolloids - specifically fecal indicator organisms, DNA, pathogens, and phytoplankton - as well as sources and fate of nitrogen. This knowledge is crucial to formulating new management policies and engineering practices that protect human and ecosystem health at the coastal margins.

  • Alistair Boettiger

    Alistair Boettiger

    Associate Professor of Developmental Biology

    Current Research and Scholarly InterestsMy lab focuses on investigating the role of three-dimensional genome organization in regulating gene expression and in shaping cell fate specification during development. We pursue this with advanced single-molecule imaging and transgenics.

  • Carol Boggs

    Carol Boggs

    Bing Director in Human Biology, Emerita

    Current Research and Scholarly InterestsI am interested in how environmental variation affects life history traits, population structure and dynamics, and species interactions in ecological and evolutionary time, using Lepidoptera.

  • Matthew Bogyo

    Matthew Bogyo

    Professor of Pathology and of Microbiology and Immunology and, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly InterestsOur lab uses chemical, biochemical, and cell biological methods to study protease function in human disease. Projects include:

    1) Design and synthesis of novel chemical probes for serine and cysteine hydrolases.

    2) Understanding the role of hydrolases in bacterial pathogenesis and the human parasites, Plasmodium falciparum and Toxoplasma gondii.

    3) Defining the specific functional roles of proteases during the process of tumorogenesis.

    4) In vivo imaging of protease activity

  • Jeannette Bohg

    Jeannette Bohg

    Associate Professor of Computer Science

    BioJeannette Bohg is an Assistant Professor of Computer Science at Stanford University. She was a group leader at the Autonomous Motion Department (AMD) of the MPI for Intelligent Systems until September 2017. Before joining AMD in January 2012, Jeannette Bohg was a PhD student at the Division of Robotics, Perception and Learning (RPL) at KTH in Stockholm. In her thesis, she proposed novel methods towards multi-modal scene understanding for robotic grasping. She also studied at Chalmers in Gothenburg and at the Technical University in Dresden where she received her Master in Art and Technology and her Diploma in Computer Science, respectively. Her research focuses on perception and learning for autonomous robotic manipulation and grasping. She is specifically interesting in developing methods that are goal-directed, real-time and multi-modal such that they can provide meaningful feedback for execution and learning. Jeannette Bohg has received several awards, most notably the 2019 IEEE International Conference on Robotics and Automation (ICRA) Best Paper Award, the 2019 IEEE Robotics and Automation Society Early Career Award and the 2017 IEEE Robotics and Automation Letters (RA-L) Best Paper Award.

  • Cara Bohon

    Cara Bohon

    Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development

    Current Research and Scholarly InterestsMy research interests have focused on the neural bases of eating disorders. I am particularly interested in the way emotion and reward is processed in the brain and how that may contribute to eating behavior and food restriction. I hope to eventually translate biological research findings into treatments.

  • Paul Bollyky

    Paul Bollyky

    Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology

    Current Research and Scholarly InterestsBacteriophages, viruses that infect bacteria, are abundant in the human body. However, their contributions to human health and disease are largely unknown. The Bollyky Lab
    studies interactions between phages and both their human and bacterial hosts with the goal of developing innovative strategies to improve human health.

  • C. Andrew Bonham, MD, FACS

    C. Andrew Bonham, MD, FACS

    Associate Professor of Surgery (Abdominal Transplantation), Emeritus

    Current Research and Scholarly InterestsTolerance induction in liver transplantation.
    Hepatocyte transplantation.